Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1

The interaction of NK inhibitory killer Ig-like receptors (KIRs) with self-MHC class I molecules mediates NK tolerance to self while conferring functional competence. Through single-cell analysis of intracellular IFN-γ production and NK clone cytotoxicity we evaluated the resting NK repertoire, analyzing the responsiveness of NK subgroups expressing discrete combinations of non-KIR and KIR class I-specific receptors. CD94:NKG2A and Ig-like transcript 2 (ILT2)-expressing cells have a modest response to class I-negative target cells, but NK cells expressing inhibitory KIRs to self-MHC class I ligands, both HLA-B and HLA-C ligands, achieve significantly higher effector capacity. There is a dose effect of KIR for self-MHC on effector capacity, but even in the most highly responsive NK cells expressing more than one inhibitory KIR for self-MHC the presentation of only one cognate MHC ligand is sufficient to abolish response. Among KIR+ cells there is preferential expression for inhibitory KIR for self-MHC. The likelihood of KIR expression is influenced by whether other KIRs are already expressed on the same cell, supporting a model of serial acquisition of KIR expression. These findings define how inhibitory receptor and autologous HLA interactions impact single-cell function and demonstrate that the resting human NK repertoire is highly attuned but variegated in response. These findings have important implications for the resting NK response to viral pathogens and malignancy, for donor selection in allogeneic hemopoietic cell transplantation, and for models of NK tolerance.

[1]  P. Parham,et al.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. , 2007, Blood.

[2]  J. Klein,et al.  Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. , 2007, Blood.

[3]  A. Thiel,et al.  CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1 , 2007, The Journal of Immunology.

[4]  P. Wernet,et al.  Relevance of C1 and C2 Epitopes for Hemopoietic Stem Cell Transplantation: Role for Sequential Acquisition of HLA-C-Specific Inhibitory Killer Ig-Like Receptor1 , 2007, The Journal of Immunology.

[5]  R. Oostendorp,et al.  Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. , 2006, Blood.

[6]  S. Gasser,et al.  Activation and self‐tolerance of natural killer cells , 2006, Immunological reviews.

[7]  S. Dakshanamurthy,et al.  A Single Polymorphism Disrupts the Killer Ig-Like Receptor 2DL2/2DL3 D1 Domain12 , 2006, The Journal of Immunology.

[8]  F. Christiansen,et al.  KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  D. Middleton,et al.  Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.

[10]  P. Parham,et al.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.

[11]  Jeffrey S. Miller,et al.  KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. , 2005, Blood.

[12]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[13]  M. Horowitz,et al.  Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. , 2005, Blood.

[14]  R. Vance,et al.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.

[15]  P. Debré,et al.  NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. , 2005, Blood.

[16]  C. Le,et al.  Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. , 2005, Blood.

[17]  Sofia Johansson,et al.  Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A. , 2005, Molecular immunology.

[18]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[19]  J. Zimmer,et al.  Cis association of Ly49A with MHC class I restricts natural killer cell inhibition , 2004, Nature Immunology.

[20]  P. Parham,et al.  The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1 1 , 2003, The Journal of Immunology.

[21]  Franco Locatelli,et al.  Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.

[22]  Mali Salmon-Divon,et al.  Models for Natural Killer Cell Repertoire Formation , 2003, Clinical & developmental immunology.

[23]  P. Parham,et al.  Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. , 2003, Blood.

[24]  Mali Salmon-Divon,et al.  Generation of the natural killer cell repertoire: The sequential vs. the two-step selection model , 2003, Bulletin of mathematical biology.

[25]  Eric Mickelson,et al.  Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets1 , 2002, The Journal of Immunology.

[26]  D Middleton,et al.  A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. , 2002, Tissue antigens.

[27]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[28]  D. G. Muir,et al.  Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes1 , 2002, The Journal of Immunology.

[29]  D. Davies,et al.  Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. , 2001, Journal of immunological methods.

[30]  P. Parham,et al.  Genetic control of human NK cell repertoire , 2001 .

[31]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[32]  D. G. Muir,et al.  Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. , 2000, Immunity.

[33]  A. Tosti,et al.  Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.

[34]  F. Lemonnier,et al.  Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. , 1999, Journal of immunology.

[35]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[36]  Eric O Long,et al.  Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.

[37]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[38]  R. Bellomo,et al.  Interleukin‐15‐induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2‐A as the only HLA class I‐specific inhibitory receptor , 1997, European journal of immunology.

[39]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[40]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[41]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.